PharVision Advisers’s Oshkosh OSK Stock Holding History

PharVision Advisers’s Portfolio OSK Stock Details OSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,930	Closed	-$250K	–	919
2025 Q3	$250K	Buy	+1,930	New	+$256K	0.14%	328

Other funds holding OSK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Greenhaven Associates Purchase, New York $8.66B AUM 17.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PharVision Advisers's OSK Position: Q4 2025 in Review

PharVision Advisers sold out of Oshkosh (OSK) in Q4 2025, closing a stake of 1,930 shares — an estimated $250K sold.

PharVision Advisers first reported a position in OSK in Q3 2025 and held it in 1 quarter. The position peaked at $250K in Q3 2025. 557 funds tracked by Wall St. Rank hold OSK as of Q4 2025.

PharVision Advisers reported no remaining Oshkosh position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,930 Oshkosh shares in Q4 2025, an estimated $250K.
PharVision Advisers first reported a position in Oshkosh in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Oshkosh position peaked at $250K in Q3 2025.
557 funds tracked by Wall St. Rank held Oshkosh as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.